Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation TCT 2024

Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Presenter: Stefano Galli

October 30, 2024

Presentation TCT 2024

TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry

Presenter: Stefano Galli

October 29, 2024

Presentation TCT 2024

TCT 361: Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Presenter: Stefano Galli

October 27, 2024

Presentation TCT 2024

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

Presenter: Kirstine Hansen

October 27, 2024

Presentation TCT 2023

TCT 817: ABSORB bioresorbable scaffold (BRS) late restenosis treated with novel Magmaris BRS

Presenter: Jorgo Kostov

October 25, 2023

Presentation TCT 2023

TCT 816: Very late Magmaris Scaffold Restenosis: A 6-year Serial Optical Coherence Tomography Case

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

TCT 141: Preliminary Results of the Resorbable Magnesium Scaffold (Magmaris) in long and multivessel lesions: data from the IT-Masters registry

Presenter: Stefano Galli

October 25, 2023

Presentation TCT 2023

TCT 81: Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 36-Month Outcomes of the BIOSOLVE-IV Registry

Presenter: Gregory Starmer

October 25, 2023

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

Presentation TCT 2022

TCT 61: Safety and efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 24-month Follow-up of the Full Cohort (2066 subjects) of the BIOSOLVE-IV Registry

Presenter: Johan Bennett

September 17, 2022

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

Presentation TCT 2020

TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Adrian Wlodarczak

October 14, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

Presentation JIM 2020

Present and future of resorbable magnesium scaffold. An expert review.

Presenter: Stefano Galli

February 13, 2020

Presentation TCT 2019

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Stefan Verheye

September 25, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

Presentation JIM 2019

Magmaris, a Resorbable Magnesium Scaffold here to stay

Presenter: Johan Bennett

February 15, 2019

Presentation TCT 2018

Imaging and Clinical Results With the Latest Magmaris Magnesium-Based Scaffold

Presenter: Alexandre Abizaid, Ron Waksman, Michael Haude

September 22, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

Presentation EuroPCR 2018

Safety and performance of the resorbable magnesium scaffold, Magmaris in a real world setting - First 200 subjects at 12-month follow-up of the BIOSOLVE-IV registry

Presenter: Stefan Verheye

May 25, 2018

Advertisement

Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry

TCT 361: Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

TCT 817: ABSORB bioresorbable scaffold (BRS) late restenosis treated with novel Magmaris BRS

TCT 816: Very late Magmaris Scaffold Restenosis: A 6-year Serial Optical Coherence Tomography Case

TCT 141: Preliminary Results of the Resorbable Magnesium Scaffold (Magmaris) in long and multivessel lesions: data from the IT-Masters registry

TCT 81: Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 36-Month Outcomes of the BIOSOLVE-IV Registry

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

TCT 61: Safety and efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 24-month Follow-up of the Full Cohort (2066 subjects) of the BIOSOLVE-IV Registry

Good Long-term Results With FANTOM BVS, but More Data Needed

TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Present and future of resorbable magnesium scaffold. An expert review.

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Magmaris, a Resorbable Magnesium Scaffold here to stay

Imaging and Clinical Results With the Latest Magmaris Magnesium-Based Scaffold

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Safety and performance of the resorbable magnesium scaffold, Magmaris in a real world setting - First 200 subjects at 12-month follow-up of the BIOSOLVE-IV registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content